- Home
- AMTB vs OPK Comparison
AMTB vs OPK Comparison
Compare AMTB & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMTB | OPK |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 922.1M | 921.2M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMTB | OPK |
|---|---|---|
| Price | $22.35 | $1.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $23.67 | $1.60 |
| AVG Volume (30 Days) | 202.2K | ★ 2.3M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | ★ 386.36 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $8.29 | N/A |
| Revenue Next Year | $7.67 | $4.24 |
| P/E Ratio | $51.17 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.62 | $0.98 |
| 52 Week High | $24.38 | $1.60 |
Technical Indicators
Market Signals| Indicator | AMTB | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 70.36 |
| Support Level | $21.98 | $1.24 |
| Resistance Level | $22.75 | $1.42 |
| Average True Range (ATR) | 0.60 | 0.04 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 46.41 | 86.71 |
Price Performance
Historical ComparisonAbout AMTB Amerant Bancorp Inc.
Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.